MosquitoBorne
Promising Trial Outcomes Transfer First Vaccine for Chikungunya, an Rising Mosquito-Borne Risk, Nearer to Actuality
Valneva’s vaccine for chikungunya, a mosquito-borne virus that creates signs corresponding to dengue and Zika, has demonstrated constructive ends in a late-stage scientific trial in keeping with The Lancet. Valneva used a much less potent type of the virus within the vaccine, which was given to three,082 of the 4,115 wholesome adults enrolled within the […]
1 min read